Actionnariat et activité des initiés pour AC Immune S.A. (ACIU): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $2.65 |
| Capitalisation | $270M |
| Bourse | NASDAQ |
| Pays | CH |
Bilan (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $152.2M | $124.4M | $156.5M | $193.6M | $160.9M | $82.2M | $31.6M | $78.5M | $36.3M | $26.8M |
| Placements à Court Terme | 0 | 0 | $30.0M | $95.0M | $65.0M | $116.0M | $91.0M | $24.6M | $129.2M | $64.7M |
| Créances | $1.4M | $3.7M | $4.1M | $1.4M | $1.6M | $975000 | $408000 | $15.0M | $1.1M | $1.3M |
| Stocks | $389000 | -$1.4M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Courants | $154.9M | $129.5M | $192.9M | $292.8M | $231.8M | $202.6M | $128.1M | $125.2M | $172.0M | $96.8M |
| Immobilisations Corporelles | $1.1M | $2.4M | $3.3M | $6.2M | $6.6M | $8.0M | $7.1M | $6.9M | $8.1M | $6.5M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | 0 | 0 | 0 | 0 | 0 | $50.4M | $50.4M | $50.4M | $50.4M | $50.5M |
| Actifs Totaux | $156.1M | $132.0M | $196.6M | $299.2M | $238.7M | $261.4M | $185.9M | $182.8M | $230.9M | $154.4M |
| Dettes Fournisseurs | $4.0M | $1.1M | $2.0M | $142000 | $2.2M | $2.0M | $929000 | $1.7M | $2.7M | $2.1M |
| Dette à Court Terme | 0 | 0 | $332000 | $652000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Courants | $9.9M | $9.8M | $13.1M | $17.5M | $14.0M | $20.0M | $11.5M | $13.6M | $100.8M | $94.8M |
| Dette à Long Terme | 0 | $494000 | $186000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Totaux | $13.7M | $15.2M | $18.9M | $26.8M | $23.3M | $29.5M | $16.9M | $22.2M | $118.6M | $109.5M |
| Réserves | -$46.9M | -$72.6M | -$121.9M | -$75.5M | -$132.8M | -$200.9M | -$264.0M | -$316.2M | -$368.2M | -$439.5M |
| Capitaux Propres | $142.4M | $116.8M | $177.6M | $272.4M | $215.5M | $232.0M | $169.0M | $160.6M | $112.3M | $44.9M |
| Dette Totale | 0 | $395000 | $518000 | $2.9M | $2.2M | $2.9M | $2.8M | $3.5M | $5.4M | $4.5M |
| Dette Nette | -$152.2M | -$124.0M | -$185.9M | -$285.7M | -$223.7M | -$195.3M | -$119.8M | -$99.6M | -$160.1M | -$86.9M |
| Fonds de Roulement | $145.0M | $119.8M | $179.8M | $275.3M | $217.7M | $182.6M | $116.6M | $111.6M | $71.2M | $2.0M |
Santé financière
| Dette / Capitaux propres | 0.12 |
| Ratio de liquidité | 0.93 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -4.04 |
Rentabilité
| Rentabilité des capitaux propres | -99.17% |
| Rentabilité du capital investi | -86.61% |
| Rentabilité des actifs | -28.70% |
| Marge brute | 100.00% |
| Marge opérationnelle | -252.25% |
| Marge nette | -246.49% |
Entreprises liées: ALDX · AMRN · ANNX · ANRO · CLLS · CTNM · DRTS
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de ACIU: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions